drugset / Trial / NCT04619108

Thrombosomes for Expanded Access Use

NCT04619108 ↗

Expanded access No longer available Cellphire Therapeutics, Inc.

Summary

Expanded use of Thrombosomes where a clinical trial with Thrombosomes is not an option, Cellphire may elect to provide the Sponsor/Investigator (S/I) expanded access to its investigational product, Thrombosomes.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Background Thrombosomes Other / unclassified — —

Indications